CLIA-waived LeadCare® II point-of-care analyzer
The world’s only CLIA-waived
blood-lead analyzer, LeadCare II improves clinical outcomes and is ideal for the
physicians’ office, health clinic, or outreach-screening program.
Safe, fast, easy, and inexpensive to use, ESA developed LeadCare II with a
grant from the U.S. Centers for Disease Control. No more waiting days for
expensive lab analysis, or worrying about losing track of a child that needs
follow-up care. LeadCare II delivers quantitative blood lead results
equivalent to those reported by outside laboratories in just three minutes. It
improves patient care by providing on-the-spot results, cuts your staffs'
result-tracking and administrative time, and qualifies for reimbursement as a
quantitative blood lead test (CPT code: 83655).
- Point-of-care results in just three minutes – eliminates
multiple visits
- Simple to operate – no special training required
- Capillary samples (two drops, 50 ěl) – easier for patient,
parent, and staff
- Accuracy and sensitivity you can count on – comparable to
reference-lab tests
- Reimbursable – CPT code: 83655; per-test cost typically
less than a reference-lab test
LeadCare II features:
- Small – 9.0 in x 6.5 in x 3.5 i
- Lightweight – 2.4 lbs
- Portable – runs on four AA battery or AC adapter
- No manual calibration or refrigeration required
- Completely safe – unique gold electrode sensor contains no mercury or other
toxic materials
|
.jpg)
